Brief: Insilico Medicine Secures $110 Million Series E Financing To Advance Ai-Driven Drug Discovery Innovation
13/03/2025 14:53
March 13 (Reuters) - Value Partners Group Ltd 0806.HK: INSILICO MEDICINE SECURES $110 MILLION SERIES E FINANCING TO ADVANCE AI-DRIVEN DRUG DISCOVERY INNOVATION INSILICO MEDICINE -SERIES E FINANCING LED BY A PRIVATE EQUITY FUND OF VALUE PARTNERS GROUP Source text: ID:nPnbNH150a Further company coverage: 0806.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Value Partners
See all newsHong Kong asset manager Value Partners' H1 net profit falls despite fee income surge
Brief: Value Partners Says Asian Income Fund Approved Under Mainland-Hong Kong MRF Scheme
Brief: Value Partners Announces Unaudited AUM Of Us$7.1 Billion As At June 30, 2026
Brief: Value Partners Recommends Final Dividend 5.5 Hk Cents Per Share
Brief: Value Partners Expects HK$660 MLN Profit For FY